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Background: RNA sequencing technologies reveal that bacteria express RNA molecules other than mRNA, rRNA or
tRNA. During the last years genome-wide bacterial transcriptomes have been shown to comprise intergenic RNA,
antisense RNA, and untranslated regions, all capable of performing diverse regulatory functions.
Results: In this study we used RNA-seq to identify 232 antisense RNAs (asRNAs) in the opportunistic pathogen
Pseudomonas aeruginosa grown under 13 different conditions. The conditions studied include exponential and
stationary growth as well as osmotic, oxidative and antibiotic stress. We found a significant overrepresentation of
asRNAs that are transcribed opposite to genes involved in cell division and in cell wall, lipopolysaccharide (LPS), and
capsule biosynthesis, most likely reflecting the conditions used in this study. A substantial number of asRNAs
significantly changed their expression under osmotic, oxidative and antibiotic stress, suggesting that asRNAs may
play regulatory roles during these conditions. We also made a comparison between the asRNAs detected in this
study in P. aeruginosa PAO1 with the asRNAs detected in two previous studies in P. aeruginosa PA14, and found
that the extent of overlap between the studies is very limited.
Conclusions: RNA-seq experiments are revealing hundreds of novel transcripts in all bacterial genomes investigated.
The comparison between independent studies that used RNA-seq to detect novel asRNAs in P. aeruginosa shows
that the overlap between the results reported is very narrow. It is necessary to address how reproducibility of these
kind of studies should be reported in order to avoid misleading conclusions when comparing data generated by
non-identical methods.Background
During the last years an increasing number of bacterial
transcriptomes have been examined with tiling arrays
and RNA sequencing (RNA-Seq) technologies, revealing
that a significant number of protein-coding genes are
also transcribed from the reverse complementary strand
in a wide range of bacterial species [1-8]. Overlapping
transcription results in the generation of antisense RNAs
(asRNA) with sizes ranging from tens to thousands of
nucleotides (nt). Regulatory roles of asRNAs were first
reported more than 30 years ago in Escherichia coli,
where plasmid-encoded asRNAs were found to nega-
tively regulate plasmid copy number [9-11]. Since then
bacterial asRNAs were only occasionally detected and* Correspondence: sm@bio.dtu.dk
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article, unless otherwise stated.therefore considered to be rare, and as late as in 2007
only about thirty bacterial asRNAs had been identified
(reviewed in [12]). However, due to the use of tiling
array and especially RNA-Seq the number of reported
asRNAs in bacterial transcriptomes is now rapidly grow-
ing. The characterization of the physiological function of
individual asRNAs is however lagging behind. AsRNAs
are known to affect the expression of the target gene by
different mechanisms (reviewed in [13]). These include:
(i) interference by convergent transcription, in which
transcription from one promoter is suppressed by a second
promoter located in the opposite strand, (ii) transcription
attenuation, in which base pairing of the asRNA to the
target mRNA causes premature transcription termination,
(iii) changes in the target RNA stability, where the asRNA
either promotes or blocks degradation or cleavage of
the mRNA by ribonucleases, (iv) asRNAs can directly
block ribosome binding, and (v) might indirectly impact
ribosome binding (either positively or negatively) byCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the expression of the opposite gene is not the only function
of certain asRNAs. Some asRNAs encode small proteins
[14], and some have the potential to act on multiple targets
in trans [15-19].
In this work, we used RNA-Seq to identify asRNAs
in the human pathogen P. aeruginosa, which can cause
severe infections, particularly in immunocompromised
and cystic fibrosis (CF) patients. The CF lung is an
osmotically stressful environment, due to the viscous,
dehydrated mucus, cellular debris and electrolytes com-
peting for a limited supply of water [20,21]. A variety of
studies have shown that P. aeruginosa encounters reactive
oxygen species (ROS) in the lungs of CF patients due
to the exaggerated, sustained and extended inflamma-
tory response, characterized by influx of neutrophils
and high concentrations of interleukin-8 [22-24]. In
addition, P. aeruginosa-infected CF patients are rou-
tinely treated with several types of antibiotics, because
early and aggressive antipseudomonal treatment regi-
mens are correlated with improved lung function and
survival of CF patients [25]. Recently, two independent
studies identified antisense transcription in P. aeruginosa.
One of the studies investigated strains PAO1 and PA14 at
early stationary growth phase and found 60 asRNAs, of
which 19 were expressed in strain PAO1 [26]. The other
study identified 384 antisense transcriptional start sites,
but not full length asRNAs, in P. aeruginosa PA14 grown
at 28°C and at 37°C [27]. The expression of asRNAs most
likely occurs in a transient manner and is dependent
on specific environmental cues. Therefore, we chose to
monitor the expression of asRNAs in P. aeruginosa
PAO1 grown in several different conditions to ensure a
comprehensive characterization of the P. aeruginosa
asRNA-ome. Accordingly, exponentially growing pop-
ulations of P. aeruginosa PAO1 were exposed to osmotic,
oxidative and antibiotic stress. The antibiotics used in
this study were ß-lactams, aminoglycosides, macrolides,
colistin and tetracycline. All the antibiotics used, with
the exception of tetracyclin, are routinely used against
P. aeruginosa infections [28-32]. Finally, the expression
of asRNAs was also investigated during exponential and
stationary growth.
Recently, we showed that library preparation for
RNA-Seq plays a fundamental role when aiming at
identifying novel transcripts [33]. Using three different
RNA-Seq library protocols with different sRNA abun-
dance, we identified over 500 novel intergenic sRNAs
in P. aeruginosa PAO1 [33,34]. Although the use of
three different libraries increased the number of novel
transcripts identified, there were significant differences in
the subset of transcripts detected in each library. Libraries
that were prepared with a size-selected fraction of RNA
were more sensitive in the detection of intergenic sRNAs[33]. In the present study we report 232 novel asRNAs
that were identified using strand-specific RNA-Seq librar-
ies that contain cDNA originating from transcripts shorter
than 500 nt [33,34].
Results and discussion
Antisense RNAs detection and classification
Exponentially growing cells of P. aeruginosa PAO1 were
exposed to sodium chloride (NaCl) and hydrogen peroxide
(H2O2) inducing osmotic and oxidative stress conditions,
respectively. The antibiotics used were piperacillin, ceftazi-
dime, aztreonam, meropenem, tobramycin, azithromycin,
colistin and tetracycline. The concentrations of antibiotics,
NaCl and H2O2 are shown in Table 1. RNA-Seq libraries
were prepared using the previously described protocol
LIB < 500, which produces strand-specific libraries that
contain cDNA originating from transcripts shorter than
500 nt [33,34]. On average 2.6% of the mapped reads cov-
ered regions antisense to previously annotated transcripts
(Additional file 1).
In total, we identified 232 novel asRNAs longer than
50 nt, of which 212 are novel transcripts. The 22
asRNAs already identified by other studies are listed
in Tables 2 and 3. Additional file 2 lists the coordinates
of the 232 asRNAs, as well as the annotation of genes
transcribed from the opposite strand. Only asRNAs
longer than 50 nt were taken into consideration. The
longest detected asRNA is 581-nt long. The asRNAs were
categorized depending on their position with respect to the
antisense gene as “start-span” (the asRNA overlaps with
the 5’ end of the antisense gene), “internal” (the asRNA
starts and ends within the antisense gene), or “end-span”
(the asRNA overlaps with 3’ the end of the gene). Thirteen
asRNAs overlapped with two contiguous genes transcribed
from the opposite strand. Some genes have untranslated
regions (UTRs) either in the 5’ or the 3’ end which can
contain regulatory elements for controlling gene expres-
sion. UTRs sometimes extend into the neighboring genes,
so we cannot rule out that some of the detected asRNAs
might actually be UTRs from neighboring genes. To
prevent mis-annotation of UTRs as asRNAs, we have
not included asRNAs that terminated less than 100 bp
to the start of a flanking gene with the same direction
as the asRNA. However we cannot rule out that some
of the novel asRNAs identified in this study might be
long UTRs belonging to flanking genes, or even novel
coding genes. It is also possible that some of the asRNAs
identified are the result of non-specific transcription and
thus have no physiological functions.
Next, we examined the distribution of antisense sRNAs
in the genome and found the asRNAs to be homogenously
distributed throughout the genome of P. aeruginosa
PAO1 (Figure 1A). A recent study by Wurtzel et al. found
that antisense sRNAs are more often found in some parts
Table 1 Concentration of antibiotics, NaCl and H2O2 used
in the stress exposure experiments
Condition Abbreviation MIC value
(μg/ml)
(μg/ml) added
at OD = 0.5
Control - - -
Aztreonam AZT 4 3xMIC
Ceftazidime CEF 2 3xMIC
Ciprofloxacin CIP 0.125 3xMIC
Meropenem MER 1 3xMIC
Tetracyclin TET 8 3xMIC
Tobramycin TOB 1 3xMIC
Azithromycin AZI 1.5 10xMIC
Colistin CO 4 3xMIC
Piperacillin PP 4 3xMIC
Hydrogen peroxyde H2O2 - 1 mM
Sodium chloride NaCl - 0.5 M
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cifically, the authors identified 384 sites with overlapping
transcription on the reverse strand, and found that the
pathogenicity island PAPI-1 harbors 5-fold more asRNA
loci compared to the core genome. In this study we do
not observe a similar enrichment of antisense transcripts
in certain parts of the genome. There are two reasons that
might explain the difference between this study and the
one from Wurtzel et al. (2012). i) The strain used in the
study is P. aeruginosa PAO1, while Wurtzel et al. (2012)
used strain PA14. The PAPI-1 island is found in strain
PA14 but not in PAO1, though it can be transferred by a
type IV pilus [35]. ii) Wurtzel et al. (2012) studied two
conditions (growth at 28°C and at 37°C, respectively).
In this study we sequenced samples from P. aeruginosaTable 2 AsRNAs detected in this study and in Ferrara et al. (2
AsRNA antisense to
P




triC RND triclosan efflux transporter > As6
gshB Glutathione synthetase < As19
PA0667 Conserved hypothetical protein < As30
PA1933 Probable hydroxylase large subunit >
As96
As97
nuoA NADH dehydrogenase I chain A > As120 2
PA2759 Hypothetical protein < As128
PA3459 Probable glutamine amidotransferase > As152
ponA Penicillin-binding protein 1A > AsponA 5
PA5480 Hypothetical protein > As246
ysxC Conserved hypothetical protein > As247 6
The 4 asRNAs detected in all 3 studies are shown in bold.growing in 12 different conditions. Studying more con-
ditions might lead to finding antisense transcription
sites in more genomic locations, and therefore avoid-
ing enrichment of expression of asRNAs associated to
a specific condition.
Functional classification and differential expression of asRNAs
Figure 1B shows the classification of genes with asRNAs
transcribed from the reverse strand in our experi-
ments according to their function. We found a signifi-
cant overrepresentation of the classes ‘Cell division’
(3.4-fold increase, P = 0.03) and ‘Cell wall / LPS / capsule’
(2.2-fold increase, P = 0.003). This overrepresentation
of genes involved in cell division and cell wall, lipopolysac-
charide (LPS), and capsule biosynthesis most likely reflects
the conditions used in this study. The conditions studied
(stationary phase, osmotic, oxidative and antibiotic stresses)
greatly affect both the bacterial replication and cell wall
synthesis, and therefore fast regulation of the genes in-
volved in these processes is essential. Indeed we observe
significant changes in expression of cell division and
LPS genes after the antibiotic treatments (data not shown),
which is in agreement with previous studies [36]. Inter-
estingly we have detected 6 asRNAs (as138-as143) that
are transcribed opposite to 7 genes of the wbp cluster
(wbpBCDE, wzy, wbpG and wbpJ) (Additional file 3). The
wbp cluster contains genes encoding proteins involved the
B-band LPS O-antigen biosynthesis in P. aeruginosa,
including genes for enzymes involved in synthesis and
transfer of sugar nucleotides and O-antigen processing
[37]. WbpB, WbpE, and WbpD are the three central
enzymes in this pathway [38]. Cirz et al. (2006) reported
that the transcription of wbp genes were decreased by
2- to 6-fold after exposure to ciprofloxacin [36]. Our012) in P. aeruginosa PAO1 [26]
This study Ferrara et al. (2012)
. aeruginosa PAO1 P. aeruginosa PAO1
Start End Length Name Start End Length
asRNA asRNA asRNA asRNA asRNA asRNA asRNA
182516 182617 102 SPA0111 182500 182700 201
448929 449284 356 SPA0113 449000 449400 401
718785 718934 150 SPA0055 719900 720200 301
2113618 2113734 117
SPA0059 2113600 2114100 501
2113817 2113927 111
982707 2982848 142 SPA0114 2982700 2982900 201
3119347 3119453 107 SPA0115 3119200 3119700 501
3866017 3866206 190 SPA0064 3865900 3866200 301
680819 5681167 349 SPA0119 5680700 5681300 601
6171684 6171915 232 SPA0121 6171700 6172000 301
183216 6183389 174 SPA0122 6183500 6183700 201
Table 3 AsRNAs detected in this study and in Wurtzel et al. (2012) [27]
AsRNA antisense to This study Wurtzel et al. (2012)
P. aeruginosa PAO1 P. aeruginosa PA14
Gene
name
Gene function Gene Gene Name Start End Length Gene locus Gene
direction
TSS of
asRNAlocus direction asRNA asRNA asRNA asRNA
dnaA Chromosomal replication initiator
protein DnaA
PA0001 > AsdnaA 1320 1784 465 PA14_00010 > 715
- Hypothetical protein PA0259 < As11 290529 290665 137 PA14_03190 < 281975
- Hypothetical protein PA0264 < As13 299094 299181 88 PA14_03420 < 313235
gshB Glutathione synthetase PA0407 < As19 448929 449284 356 PA14_05310 < 463561
cupA1 Fimbrial subunit CupA1 PA2128 > As102 2342397 2342560 164 PA14_37060 < 3300832
trxB1 Thioredoxin reductase 1 PA2616 > As119 2959629 2959767 139 PA14_30280 < 2622144
nuoA NADH dehydrogenase I chain A PA2637 > As120 2982707 2982848 142 PA14_30020 < 2599053
rmf Ribosome modulation factor PA3049 > As135 3414435 3414491 57 PA14_24650 < 2154716
fadD2 Long-chain-fatty-acid–CoA ligase PA3300 < As150 3697506 3697616 111 PA14_21340 > 1849717
fpvB Second ferric pyoverdine receptor FpvB PA4168 > As174 4666087 4666202 116 PA14_09970 < 856527
pilY1 Type 4 fimbrial biogenesis protein PilY1 PA4554 >
As197 5101107 5101200 94
PA14_60310 > 5374009
As198 5101511 5101611 101
ponA Penicillin-binding protein 1A PA5045 > AsponA 5680819 5681167 349 PA14_66670 > 5952559
wzm Membrane subunit of A-band LPS
efflux transporter
PA5451 < As243 6141133 6141239 107 PA14_71960 < 6414559
ysxC Ribosome biogenesis GTP-binding
protein YsxC
PA5492 > As247 6183216 6183389 174 PA14_72480 > 6456518
The 4 asRNAs detected in all 3 studies are shown in bold.
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ing the full transcriptome show the same trend after
ciprofloxacin and tobramycin exposure, with down-
regulation of the wbp genes of 2- to 15-fold, and down-
regulation of the asRNAs as138-as143 of 2- to 10-fold.
However further investigations are required to assessFigure 1 Distribution and targets of antisense sRNAs. A. Distribution o
marked by a black line. B. Classification of genes showing antisense transcr
functional classes that are significantly overrepresented (P < 0.05) among thwhether these asRNAs affect the levels of the wbp
genes encoded on the opposite strand.
Figure 2A represents the number of asRNAs whose
expression is significantly changed during the conditions
tested (P < 0.01). A substantial number of asRNAs sig-
nificantly change their expression, indicating that theirf antisense sRNAs in the genome of P. aeruginosa PAO1. Each asRNA is
iption according to PseudoCap functional classes. Asterisks (*) denote
e 232 asRNAs.
Figure 2 Differential expression of asRNAs. A. Number of asRNAs whose expression is significantly changed during the conditions tested.
B. Heatmap and hierarchical cluster analysis of expression of the most differentially expressed asRNAs in the conditions representing osmotic,
oxidative and antibiotic stress compared to the untreated control (P < 0.01). Green color represents asRNAs with high expression, and brown
color indicates asRNAs with low expression.
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conditions tested. A hierarchical cluster analysis of expres-
sion of the most differentially expressed asRNAs illustrates
how related conditions show similar patterns of asRNA
expression (Figure 2B). The treatments with three of the
β-lactams (CEF, PP, AZT), whose modes of action are
alike, are clustered together. The β-lactam not clustered in
this group is meropenem, a carbapenem which displays a
much faster time-kill curve than the other three β-lactams
tested (data not shown). Additional file 4 lists the asRNAs
differentially transcribed in our conditions, as well as their
fold-change in expression. We anticipate that these data
will be important to understand the regulation of genes
that show antisense transcription on the reverse strand.
In most cases we do not observe a clear and significant
correlation between the transcriptional levels of asRNAs
and their target genes. This makes it difficult to infer
the mode of action of asRNAs, and it might indicate that
the role of most asRNAs is to fine-tune the regulation of
gene expression. This is known to be the case for some
sRNAs in Pseudomonas species [39,40]. In addition
asRNAs can regulate the translation of their target
genes either positively or negatively, without affecting
their transcriptional levels. Thus the level of expres-
sion alone cannot explain the mechanism of action of
asRNAs, and more experiments will be needed in order
to determine how asRNAs regulate their target genes.Comparison between asRNAs detected in different studies
Recently two independent studies used RNA-Seq to inves-
tigate transcription in P. aeruginosa and revealed novel
asRNAs. One of the studies investigated strains PAO1 and
PA14 grown aerobically in Brain Heart Infusion (BHI) rich
medium at 37°C and harvested at early stationary phase
[26]. The authors found 60 asRNAs. Interestingly, a
number of these asRNAs were strain-specific or showed
strain-specific expression: 19 asRNAs were only expressed
in strain PAO1, 29 were only expressed in strain PA14,
and 12 were expressed in both strains. The other study
investigated P. aeruginosa PA14 grown aerobically at
28°C and at 37°C in LB medium and harvested at early sta-
tionary phase [27]. The authors identified 384 transcription
start sites with overlapping transcription on the reverse
strand. However, due to their library preparation protocol,
Wurtzel et al. (2012) could not determine the length of
the asRNAs, but only the antisense transcription start sites
[27]. In this study, we identified 232 asRNAs with lengths
ranging from 50 to 581 nt. We did not take into consider-
ation neither asRNAs shorter than 50 nt, nor asRNAs that
might be suspected to be UTRs of flanking genes. This
might explain why we identify considerably fewer asRNAs
than Wurtzel et al. (2012). Figure 3 represents the overlap
between the asRNAs detected in this study and the two
previous ones. Only a small partial overlap between
studies is observed. The overlap between pairs of studies
Figure 3 Comparison between asRNAs detected in different studies. Venn diagram representing the asRNAs detected in this study, Wurtzel
et al. (2012) [27] and Ferrara et al. (2012) [26].
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detected in all three studies (Tables 2, 3 and 4). These
asRNAs are transcribed antisense to the glutathione
synthetase gene gshB, the NADH dehydrogenase I chain
A gene nuoA, the ribosome biogenesis GTP-binding
protein YsxC gene ysxC, and the penicillin-binding protein
1A gene ponA. We have validated the expression of the
latter asRNA, from now on called AsponA, using 5’- and
3’-RACE. The coordinates of asponA were very similar be-
tween the RNA-Seq data and the RACE experiments, with
differences of up to 19 nt between the two techniques.
AsponA is upregulated upon aztreonam (2.9-fold), pi-
peracillin (2.8-fold), and ciprofloxacin (2-fold) exposure,
and downregulated during meropenem (−2-fold), colistin
(−3-fold), tobramycin (−5.4-fold), and tetracycline (−5.6-fold)
exposure. AsponA overlaps with the predicted −10 and −35
σ70 promoter elements of the ponA gene (Additional file 5).
Due to the location of AsponA, we hypothesized that it
probably belongs to the class of asRNAs that prevent the
transcription or translation of the opposite gene, either by
transcription interference or by directly blocking ribosome
binding. Wurtzel et al. (2012) and Ferrara et al. (2012)
detected the expression of AsponA in P. aeruginosa
PA14 and PAO1 [26,27].
The lack of overlap between the reported asRNAs may
be caused by the different characteristics of each work, as
(i) different growth conditions, (ii) different P. aeruginosa
strains, and (iii) different methods to perform RNA-seq
were used in each of them. (i) The three studies investi-
gated different P. aeruginosa strains (PAO1 and PA14)
grown under different conditions, which may account for
part of the differences in the asRNAs detected. As previ-
ously mentioned, the level of expression of asRNAs varies
greatly that in the different conditions used in our experi-
ments (Figure 2), and in consequence the asRNAs that are
detected by RNA-Seq in each condition. (ii) The evolutionof bacterial sRNAs appears to be rapid and, as a result,
sequence similarities between sRNAs are limited, even
between relatively closely related species [41]. In a previous
study we showed that, out of 513 novel intergenic sRNAs
detected in P. aeruginosa PAO1, the sequences of 88%
of the sRNAs are not conserved outside P. aeruginosa,
indicating that the extent of conservation in other
Pseudomonas species is limited [33]. Ferrara et al. (2012)
have reported that even under the same growth conditions,
different strains of P. aeruginosa (PAO1 and PA14) express
different sets of both intergenic and antisense sRNAs [26].
However when comparing studies that investigated the
same strain, the extent of the overlap is still small (Figure 3).
We considered whether the expression of strain-specific
asRNAs was due to the existence of antisense promoters
that were present in only one of the two strains. However,
upon examination of strain-specific asRNAs, we observed
that the predicted antisense promoters were present in both
strains even if antisense transcription was only detected in
one of them. (iii) We hypothesize that the main cause for
the limited overlap between the studies may be the biases
arising from the technical variation between the studies.
These three studies used considerably different RNA ex-
traction methods, RNA-Seq library preparation protocols,
sequencing platforms and bioinformatic analysis pipelines.
Library preparation for RNA-seq experiments requires
multiple enzyme-catalyzed steps such as sequential
oligonucleotide adapter ligations to the 5’and 3 ends of
RNAs, reverse transcription (RT), and PCR. RNA ligase
preferences may contribute to the observed bias in sRNA
detection [42-45], as well as the RT reaction and PCR
[46-48]. The biases in sRNA detection could even be
caused by the use of different buffer compositions and
additives that modify enzymatic activity. Hafner et al.
(2011) investigated the biases associated to the adapter
ligation steps involved RNA-seq library preparation [42].
Table 4 AsRNAs detected in Ferrara et al. (2012) [26] and in Wurtzel et al. (2012) in P. aeruginosa PA14 [27]
AsRNA antisense to Ferrara et al. (2012) Wurtzel et al. (2012)
P. aeruginosa PA14 P. aeruginosa PA14
Gene name Gene function Gene
direction
Name Start End Length TSS of asRNA
asRNA asRNA asRNA asRNA
PA14_04820 TetR family transcriptional regulator > SPA0112 425649 426248 600 426072
gshB Glutathione synthetase < SPA0113 463700 464100 401 463561
PA14_22270 Recombinase < SPA0018 1940100 1940300 201 1941053
PA14_28290 Hypothetical protein > SPA0116 2446100 2446200 101 2446191
nuoA NADH dehydrogenase subunit A < SPA0114 2599000 2599200 201 2599053
PA14_35720 Hypothetical protein < SPA0019 3176100 3176300 201 3176580
PA14_46460 Hypothetical protein < SPA0020 4134300 4134700 401 4134289
purC Phosphoribosylaminoimidazole-succinocarboxamide
synthase
< SPA0168 4553300 4553400 101 4553302
PA14_51540 Transposase < SPA0169 4583200 4583500 301 4583062
PA14_59370 Hypothetical protein < SPA0021 5288100 5288500 401 5288463
PA14_59580 Transposase < SPA0022 5303200 5303500 301 5302248
PA14_59840 Hypothetical protein > SPA0023 5330700 5330900 201 5330858
ponA Penicillin-binding protein 1A > SPA0119 5951200 5952700 1501 5952559
PA14_69050 Hypothetical protein > SPA0173 6157800 6158100 301 6157722
ysxC Ribosome biogenesis GTP-binding protein YsxC > SPA0122 6456400 6456600 201 6456518
The 4 asRNAs detected in all 3 studies are shown in bold.
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RNAs, and that secondary and tertiary structures of
RNAs affected the efficiency of 5’- and 3’-adapter ligation
during library preparation. The sequences of 5’ and 3’
adapters were also found to affect the ligation yields
[42]. In line with these results, another study also demon-
strated that RNA and RNA-adapter secondary structures
drastically influences RNA ligation efficiencies [43].
Another investigation reported that increased variability
of adapter sequences helps to increase the diversity of
RNAs ligated [44]. Recent systematic investigations have
revealed method-dependent biases in miRNA quantifica-
tion [49,50]. Based on identical starting material, these
studies demonstrated that alternative library preparation
methods resulted in entirely different miRNA expression
levels. It was observed that the detection of miRNAs by
RNA-seq was strongly biased towards certain miRNAs,
preventing the accurate determination of absolute num-
bers of transcripts [49]. However the biases were found
to be systematic and highly reproducible and differential
expression results between samples obtained by qPCR
and RNA-seq were strongly correlated, showing that
RNA-seq is suited for determining relative expression
differences between samples [49]. Unexpectedly, the ob-
served bias was mostly independent of the sequencing
platform but strongly determined by the method used
for library preparation. Library replicates gave similar
results, which indicates that the data bias was likelycaused by differences inherent to the cDNA preparation
protocols [49]. In a previous study, we also generated
different RNA-seq libraries to identify bacterial sRNAs
[33]. Two libraries only included the RNA fractions
shorter than 500 nt and shorter than 200 nt, respectively.
Another library contained information on the full transcrip-
tome. Almost all previously known sRNAs and over 500
novel intergenic sRNAs were identified in P. aeruginosa
with this approach. There were significant differences in
the subset of transcripts detected in each library [33],
and the libraries that did not include larger transcripts
were clearly superior in detecting sRNAs. All these in-
vestigations underscore the importance of library prepar-
ation strategy and relative sRNA abundance for successful
sRNA detection, and show that in order to increase the
number of sRNAs detected it is required to apply different
parallel sequencing strategies.
Conclusions
RNA-Seq was used to identify and quantify 232 asRNAs in
the opportunistic pathogen P. aeruginosa growing under in
13 different conditions, including osmotic, oxidative and
antibiotic stress, and exponential and early stationary phase.
Due to our library preparation protocol, only asRNAs
ranging approximately from 50 to 500 nt were detected.
Thus the number of asRNAs provided in this study is most
likely an underestimate as longer asRNAs have not been in-
cluded. These data are important for the understanding of
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on the reverse strand. However the large number of
asRNAs detected makes it difficult to unravel functionality
and physiological impacts of antisense transcription, and
this paper should therefore be read as a documentation
of the potential asRNA repertoire from which specific
studies can be designed. In addition, we present data
showing that in several cases growth conditions impact
on the expression levels of asRNA, which suggest that at
least some of the asRNAs may play roles in physiological
adaptation to changing conditions. A significant number
of asRNAs were transcribed opposite to genes involved in
cell division and in cell wall, lipopolysaccharide (LPS), and
capsule biosynthesis. A substantial number of antisense
sRNAs significantly changed their expression during early
stationary phase and under osmotic, oxidative and anti-
biotic stress, suggesting that asRNAs may play a regula-
tory role during these conditions.
Finally, we compare our results with those obtained by
others in order to document that detection of these new
types of potential regulatory molecules is not trivial and
that choice of detection and documentation methods is
truly important. One of the challenges of performing
genome-wide expression studies of sRNAs is to compare
the extremely large data sets resulting from different
RNA-Seq studies, as library preparation protocols, se-
quencing platforms, and thresholds for detecting tran-
scripts differ from study to study. Our comparison of
three independent studies that used RNA-seq to detect
novel asRNAs in P. aeruginosa shows that the extent of
overlap between the results reported is very limited. It
is necessary to address considerations like what is an
appropriate threshold of reads for transcript detection,
or how reproducibility should be reported in order to
avoid misleading conclusions when comparing data
generated by non-identical methods. In addition, pub-
lic databases are already and will be needed for sharing,
analyzing, and storing transcriptomic data. Apart from
sharing and comparing RNA-seq data, the validation
and functional characterization of the hundreds of
novel sRNAs now being reported will also be a major
challenge of current RNA research.
Methods
Growth conditions
Growth in Luria–Bertani (LB) broth (250 rpm, 37°C)
or on LB plates at 37°C was used throughout this
study. Overnight cultures of Pseudomonas aeruginosa
PAO1 were diluted to a starting OD600 of 0.01 and
grown to an OD600 of 0.5, at which an antibiotic, 0.5 M
NaCl or 1 mM hydrogen peroxide was added. The final
concentrations of antibiotics are shown in Table 1.
Concentrated stock solutions of H2O2 and all antibiotics
were prepared fresh daily. Cells were harvested 1 hourafter the addition of antibiotics, NaCl and H2O2. Early-
stationary phase cells were harvested from cultures grown
to an OD600 of 3. RNA was extracted and used to make
RNA-Seq libraries LIB < 500 (described below). Experiments
were performed in duplicates.
MIC value calculation
Minimum inhibitory concentrations (MIC) of P. aeruginosa
PAO1 were assessed using both the broth microdilution
procedure and E-test strips.
Broth microdilution. LB medium was added to all wells
of a 96-well microtiter plate loaded with serially diluted
antibiotics. Each well was inoculated with P. aeruginosa
PAO1 at a final concentration of 5 × 105 cfu/ml. The plates
were incubated for 24 hours (250 rpm, 37°C). Following
incubation, the optical density of all wells was measured
and the lowest concentration showing complete inhibition
of growth was recorded as the MIC for that antibiotic. The
experiments were performed in triplicates. Concentrated
stock solutions of all antibiotics were prepared fresh daily.
E-Test. E-test (bioMérieux AB BIODISK) strips were
used according to the manufacturer’s instructions. LB
plates were inoculated equal amount of P. aeruginosa
PAO1 cells. After drying, the E-test strips were placed
on the top of the plates. The MIC values were read
after 16 h of incubation at 37°C. The experiments were
performed in triplicates.
RNA isolation
Harvested cells were mixed immediately with 0.2 volumes
of STOP solution (95% ethanol, 5% phenol) and pelleted
by centrifugation. Total RNA was extracted with Trizol
(Invitrogen). Removal of DNA was carried out by treatment
with DNase I (Fermentas) in combination with the RNase
inhibitor RiboLock (Fermentas). The integrity of total RNA
and DNA contamination were assessed with an Agilent
2100 Bioanalyzer (Agilent Technologies).
Removal of 23S, 16S and 5S rRNAs
The 23S, 16S and 5S rRNAs were removed by subtractive
hybridization using the MICROBExpress kit (Ambion)
with modifications as previously described [33,34].
Capture oligonucleotides complementary to the rRNAs of
P. aeruginosa PAO1 were used (Additional file 6). Removal
of rRNAs was confirmed with an Agilent 2100 Bioanalyzer
(Agilent Technologies).
Library preparation and RNA sequencing
Sequencing libraries were constructed as previously
described, following LIB < 500 and LIB > 100 protocols
[33,34]. Each type of library was prepared in duplicate
using RNA extracted from biological replicates. Libraries
LIB < 500 are strand-specific and contain cDNAs originating
from transcripts shorter than 500 nt. Libraries LIB > 500
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performed by running total RNA on 10% polyacrylamide
gels containing 10 M urea. Gel slices corresponding to
RNAs up to 500 nt were excised, followed by elution of
RNA in 0.4 M NaCl and precipitation with ethanol. The
5S rRNA was depleted as previously described, followed
by treatment with Tobacco Acid Pyrophosphatase
(Epicentre Technologies) at 37°C for 90 min. Tobacco Acid
Pyrophosphatase (TAP) is used to convert 5’-triphosphate
RNA into 5’-monophosphate RNA, which is important for
correct adapter ligation. This was followed by treatment
with RNase III (Ambion) for 10 min at 37°C to fragment
the RNA. RNase III fragments RNA into smaller pieces
containing a 5’-phosphoryl group and a 3’-hydroxyl group,
which is important for specific adapter ligation in the
next step. Sequential ligation of RNA 3’ and 5’ adapters
was performed using the adapters and enzymes from the
TruSeq Small RNA Sample Preparation kit (Illumina).
Next, reverse transcription followed by PCR amplification
was performed to form cDNA constructs based on the
RNA fragments ligated with 3’ and 5’ adapters, selectively
enriching fragments with adapter molecules on both ends.
The reverse transcription and subsequent PCR amplifica-
tion were performed using the enzymes and reagents from
the TruSeq Small RNA Sample Preparation kit (Illumina).
Libraries LIB > 100 contain cDNA from all RNAs tran-
scribed with the exception of 23S, 16S and 5S rRNAs.
This type of library was prepared using using the TruSeq
RNA Sample Preparation kit (Illumina) following the
manufacturer’s instructions. Agencourt AMPure XP beads
(Beckman Coulter Genomics) were used for the post-PCR
clean-up. After each step the samples were validated using
an Agilent 2100 Bioanalyzer (Agilent Technologies), and
the final concentration was measured using a Qubit 2.0
Fluorometer (Invitrogen). The libraries were sequenced
using the Illumina HiSeq2000 platform with a paired-end
protocol and read lengths of 100 nt.
Data analysis
Our analysis pipeline is described in detail in Gómez-Lozano
et al. (2014) [34]. Briefly, reads were mapped onto the
P. aeruginosa PAO1 genome (RefSeq Accession No.
NC_002516) using the Bowtie 2 short read aligner [51].
Read alignments from Bowtie 2 were handled using
SAMtools [52]. Information about the number of reads
of each library used for asRNA detection can be found
in Additional file 1. In order to obtain normalized ex-
pression intensities of the read coverage depth at each
position in the genome, the number of reads in each
replicate was normalized according to the total num-
ber of reads in the library, and expression intensities
from replicate samples were averaged. A custom-made
script was designed to detect novel transcripts antisense to
annotated genes (Additional file 7) [34]. Only transcripts ofat least 50 nt were considered further. The resulting tran-
scripts from automatic classification were re-evaluated by
visual inspection. An analysis of variance (ANOVA) was
performed on the average expression of the transcripts to
determine those with differential expression between the
conditions tested (P-value <0.05 and fold change 2). Se-
quencing libraries LIB < 500 have been submitted to the
European Nucleotide Archive under accession number
PRJEB6998 (www.ebi.ac.uk/ena/data/view/PRJEB6998).
Rapid amplification of cDNA ends (RACE)
Additional file 6 lists primers and adapters used.
5’ RACE. 2 μg rRNA-depleted RNA was incubated
with 10 U of Tobacco Acid Pyrophosphatase (Epicentre
Technologies) at 37°C for 1 h to convert RNA 5’
triphosphates in 5’ monophosphates. The same amount
of control RNA was incubated under the same conditions
in the absence of the enzyme. Reactions were stopped by
phenol-chloroform extraction, followed by etanol-sodium
acetate precipitation. Precipitated RNAs were redissolved
in water, mixed with 500 pmol of 5’ RNA adapter, heat-
denatured at 95°C for 5 min, then quick-chilled on ice. A
short RNA adapter was ligated was ligated with 50 U of T4
RNA ligase (Thermo Scientific) at 37°C for 1 h. Reactions
were stopped by phenol-chloroform extraction, followed
by ethanol–sodium acetate precipitation. Precipitated
RNAs were re-dissolved in 20 μl water. Then 10 μl of
5’adapter-ligated RNA was reverse-transcribed using 2 pmol
of primer complementary to the sRNA (5’-GSP1) and the
Thermoscript RT-PCR system (Invitrogen) according to the
manufacturer’s instructions. Reverse transcription (RT) was
performed in three subsequent 20 min steps at 55°C, 60°C,
and 65°C, followed by treatment with RNase H. Primers
were removed using the NucleoSpin Gel and PCR
Clean-up kit (Macherey-Nagel). The products of RT were
amplified using 10 pmol of another primer complementary
to the sRNA (5’-GSP2) and 10 pmol the 5’ adapter-specific
primer, together with the Maxima Hot Start PCR Master
Mix (Thermo Scientific) according to the manufacturer’s
instructions. Negative controls were performed using
the 5’ adapter-ligated RNA as template. The PCR prod-
ucts were resolved and purified using E-Gel SizeSelect
2% Agarose gels (Invitrogen). Products were sequenced
with 5’-GSP2 and 5’ adapter-specific primers by LGC
Genomics GmbH (Germany).
3’ RACE. 2 μg rRNA-depleted RNA was dephosphorylated
with calf intestinal alkaline phosphatase (New England
Biolabs) at 37°C for 1 h. Reactions were stopped by phenol-
chloroform extraction, followed by etanol-sodium acetate
precipitation. Ligation was done as above with a 3’ RNA
adapter with a 3’-inverted deoxythymidine (3’-idT). RT
was carried out as described, but with 10 pmol of a sin-
gle primer complementary to the 3’ RNA adapter. PCR
amplification, band purification and sequence analysis
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of RNA were performed in the presence of 20 units of
RiboLock RNase Inhibitor (Thermo Scientific).
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